Navigation Links
Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
Date:9/16/2008

CAMBRIDGE, Mass., Sept. 16 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced today that Dr. Joseph Kovalchin will make a poster presentation titled "Evidence of Specific T-cell Priming from the First-in-Man Single Ascending Dose Study of Peptide Copolymer PI-2301 for the Treatment of Multiple Sclerosis " on Thursday, September 18th from 3:30 - 5:00 p.m. in Exhibit Hall 220C, at the Palais Des Congres de Montreal, Canada at the World Congress on Treatment and Research in Multiple Sclerosis. The Congress is expected to attract over 3,500 participants from around the globe -- clinicians, clinical researchers, and basic scientists. This will be the largest single gathering of MS clinicians and researchers in 2008.

PI-2301 is currently in a Phase Ib multiple-ascending dose, double-blind, placebo-controlled randomized study in subjects with multiple sclerosis. Following establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009.

PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva Pharmaceuticals). PI-2301 has been designed to be more efficacious and more convenient (weekly versus daily dosing) than Copaxone for the treatment of multiple sclerosis. PI-2301 works through immune modulation by enhancing the regulatory response of the immune system and thereby controlling the pathogenic autoimmune response observed in some diseases. In a Phase I single ascending dose, double blind placebo controlled randomized study, all doses of PI-2301 were safe and well tolerated, and no serious adverse events were observed. Pharmacodynamic assays demonstrated evidence of immune exposure consistent with the pharmacologic mechanism of action for PI-2301, and dose-dependent pharmacokinetics was observed.

PI-2301 has been optimized using P
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Peptimmune Announces First Close of Series D Private Financing
2. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
3. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
4. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
5. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
8. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
10. Volcano Presentation at Thomas Weisel Conference to Be Webcast
11. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Rust removal is one of home maintenance's ... could be damaged. To help rust contractors make it less ... rust remover it called Rusterizer. It announced that ... discount. , My Cleaning Products explained that rust could damage ... staining them. The first one, it said, happens when ...
(Date:5/16/2013)... Oven Industries, Inc. has been an industry leader ... since 1964. Expertly designed, the proportional-integral-derivative PID temperature ... As one of the most commonly used ... feedback system, which helps minimize errors. With three-term control, ... process, using a control element, like a valve or ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a trusted ... the nation,s largest regional health plans, will debut ... Insurance Plans (AHIP) Institute 2013 conference on June ... results showing how health insurance companies across the ... consumer and marketplace demands for increased healthcare transparency. ...
(Date:5/16/2013)... , May 16, 2013 ... research report is available in its ... Competitor Analysis: Therapeutic Proteins – ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ... The new Competitive Intelligence ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2New PID Temperature Controllers Announced by Oven Industries Inc. 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... a professor of electrical and computer engineering and Director ... California, Santa Barbara, has been named winner of the ... (ESDA). "The ESDA research award is ... ideas that advance the field of electrostatic discharge. Professor ...
... 2011 Molecular diagnostics company GenturaDx announced the ... appointment of three initial members: Dr. Keith Jerome, ... Dr. Gregory Tsongalis, Ph.D., H.C.L.D., F.A.C.B. The board ... and the commercial market related to initial test ...
... PRA, a leading Clinical Research Organization, announces that ... group will speak at VIBPharma,s 7th Annual Pharmacovigilance, Drug ... Belgium from 22-23 November 2011.  PRA will also host ... will be available to discuss PRA,s approach to pharmacovigilance. ...
Cached Biology Technology:UCSB professor receives award for graphene electronics research 2GenturaDx Announces Formation of Scientific Advisory Board 2PRA Expert to Present at Pharmacovigilance Conference 2
(Date:5/16/2013)... May 16, 2013 Integrated Biometrics patented ... a custom thin film transistor camera introduces Sherlock, ... roll image in the smallest and lightest form ... Appendix F Mobile ID FAP 45, Certified scanner ... in size and weight when compared to optical ...
(Date:5/16/2013)... trigger hematopoiesis at sites outside the bone marrow ... Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a specific ... of blood cells. , Balanced hematopoiesis is essential for ... hematopoiesis takes place mainly in the liver and the ... marrow, and this tissue normally serves as the sole ...
(Date:5/16/2013)... in Cameroon and the manager of San Diego Zoo ... prestigious Whitley award. The Whitley award is an ... because it celebrates the extraordinary achievements of some of ... Abwe was selected for the award due to his ... and its wildlife inhabitants., HRH The Princess Royal, the ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3
... of pigmentation patterns on mollusk seashellswhich could aid ... to be a challenging feat for researchers. Now, ... Pittsburgh and University of California, Berkeley, researchers have ... snail Conus to generate a model ...
... goes the cynical saying with television and newspaper editors. In other ... the big story on the front page. So one might ... and unhappy types of words like "war," " funeral," "cancer," ... "hero." Or take Twitter. A popular image of what people ...
... 2012: A research collaboration between the Wyss Institute ... Children,s Hospital Boston has developed "smart" injectable nanotherapeutics ... to the cells of the pancreas. Although this ... before being ready for clinical use, it could ...
Cached Biology News:Breakthrough model reveals evolution of ancient nervous systems through seashell colors 2We may be less happy, but our language isn't 2We may be less happy, but our language isn't 3New 'smart' nanotherapeutics can deliver drugs directly to the pancreas 2